Scripps Networks News

Scripps Networks Technology Networks / Apr 27, 2022

Crafting DIY Apps Market Report 2022 Covers latest revenue Study with Top Countries Data and Top key

Scripps Networks Fierce Biotech / Apr 25, 2022

Immunotherapy is one of the more appealing and effective kinds of cancer treatment when it works, but the relatively new approach is still fairly limited in the kinds of cancer it can be used for. | Immunotherapy is one of the more appealing and effective kinds of cancer treatment but is still fairl…

Scripps Networks Fierce Biotech / Apr 25, 2022

A new study from a team of researchers in Toronto found that a specific kind of “off-the-shelf” CAR-T treatment may be able to fight cancer tumors without attacking the host’s body, with the lead r | A new study from a team of researchers in Toronto bolsters support for a novel “off-the-shelf” CAR-T…

Scripps Networks Fierce Biotech / Apr 22, 2022

A month after Vallon Pharmaceuticals’ one and only clinical-stage asset failed its first phase 1 test, the company is looking for an escape route to save the business. | A month after Vallon Pharmaceuticals’ one and only clinical-stage asset failed its first phase 1 test, the company is looking for…

Scripps Networks Fierce Biotech / Apr 22, 2022

Astellas’ gene therapy strategy is sinking deeper into the mire. | Astellas’ gene therapy strategy is sinking deeper into the mire. Having reviewed the data on its Duchenne muscular dystrophy (DMD) therapies, the Japanese drugmaker has decided to scrap the candidates, triggering a $170 million impai…